Prognostic factors among patients with pathological Grade Group 5 prostate cancer based on robot-associated radical prostatectomy specimens from a large Japanese cohort (MSUG94)

Sasaki, Takeshi; Ebara, Shin; Tatenuma, Tomoyuki; Ikehata, Yoshinori; Nakayama, Akinori; Kawase, Makoto; Toide, Masahiro; Yoneda, Tatsuaki; Sakaguchi, Kazushige; Teishima, Jun; Makiyama, Kazuhide; Kitamura, Hiroshi; Saito, Kazutaka; Koie, Takuya; Koga, Fumitaka; Urakami, Shinji; Inoue, Takahiro

doi:10.1007/s00345-024-04864-y

World J Urol

2024

DOI: 10.1007/s00345-024-04864-y

|View full text |Cite

Prognostic factors among patients with pathological Grade Group 5 prostate cancer based on robot-associated radical prostatectomy specimens from a large Japanese cohort (MSUG94)

Takeshi Sasaki,

Shin Ebara,

Tomoyuki Tatenuma

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Prostate cancer screening; empirical clinical practice conducted for 70 years

Takahashi

2024

World J Urol

View full text Add to dashboard Cite

Prostate cancer screening; empirical clinical practice conducted for 70 years

Takahashi

2024

World J Urol

View full text Add to dashboard Cite

Overall Survival and Cancer-Specific Mortality in Patients with Prostate Cancer Undergoing Definitive Therapies: A Narrative Review

Kawase,

Nakane,

Iinuma

et al. 2024

JCM

View full text Add to dashboard Cite

The overall survival (OS) of patients with prostate cancer (PCa) who receive locally definitive therapy is generally better than that of patients who do not receive definitive therapy. There is no difference in the incidence of local recurrence or distant metastasis between treatment modalities. Because the prognosis of PCa is relatively good, many studies have focused on quality of life after treatment as an endpoint. However, a limited number of patients develop biochemical recurrence after definitive treatment for PCa and subsequently develop distant metastasis or die from PCa. Therefore, we believe that preventing local recurrence and distant metastasis and prolonging the OS should be emphasized when selecting a treatment modality for PCa. In this review, the significance and usefulness of radical prostatectomy and radiation therapy as the main modalities of definitive therapies for local PCa and locally advanced PCa were evaluated, as well as the outcomes of OS and PCa-specific mortality and the treatment options after biochemical recurrence to improve the oncological outcomes.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Prognostic factors among patients with pathological Grade Group 5 prostate cancer based on robot-associated radical prostatectomy specimens from a large Japanese cohort (MSUG94)

Cited by 2 publications

References 26 publications

Prostate cancer screening; empirical clinical practice conducted for 70 years

Prostate cancer screening; empirical clinical practice conducted for 70 years

Overall Survival and Cancer-Specific Mortality in Patients with Prostate Cancer Undergoing Definitive Therapies: A Narrative Review

Contact Info

Product

Resources

About